Skip to main content

Table 7 Characteristics of the included POAG studies in meta-analysis

From: Genetic association between CDKN2B/CDKN2B-AS1 gene polymorphisms with primary glaucoma in a North Indian cohort: an original study and an updated meta-analysis

SNP

Year

Author

Country

Ethnicity

Genotyping

Case

Con

OR

p value

Source

Association (yes/no)

rs1063192 (A > G)

 

2016

Ng

Australia

Caucasian

Illumina

2241

3176

1.43 (1.32–1.55)

3.76 × 10−18

PB

Yes

 

2016

Abu-Amero

Saudi Arabia

Caucasian

Taqman

87

94

0.94 (0.54–1.59)

0.799

HB

No

 

2015

Burdon

Australia

Caucasian

PCR

67

1919

1.47 (1.03–2.11)

0.033

PB

Yes

 

2015

Chen

China

Asian (Han Chinese)

Sequenom

1157

934

0.85 (0.72–1.00)

0.047

HB

Yes

 

2015

Williams

South African

African

Illumina

215

214

2.58 (0.21–31.4)

0.4585

HB

No

 

2015

Philomena-din

India

Asian

PCR

97

371

Nd

0.95

HB

No

 

2012

Mabuchi

Japan

Asian

RT PCR

425

191

Nd

Nd

HB

No

 

2014

Michael

Pakistan

Asian

Taqman

268

233

0.91 (0.68–1.21)

0.48

HB

No

 

2013

Liu

USA

African American

RT PCR

1150

999

0.85 (0.67–1.06)

0.15

PB

No

 

2013

Liu

USA

West African

RT PCR

483

593

0.98

N/A

PB

No

 

2012

Cao

West Indies

Afro- Carribean

PCR

272

165

0.39 (0.22–0.69)

0.0008

PB

Yes

 

2012

Osman (GWAS)

Japan

Asian

PCR

1393

6591

0.79 (0.71–0.86)

5.68 × 10−5

PB

Yes

 

2012

Osman

Japan

Asian

PCR

1800

7207

0.73 (0.64–0.82)

1.73 × 10−7

PB

Yes

 

2012

Dimasi

Australia

Caucasian

Sequemass

876

883

0.74 (0.64–0.85)

2.2 × 10−5

PB

Yes

 

2012

Takamoto

Japan

Asian

Taqman

183

514

1.41 (1.02–1.96)

0.0381

HB

Yes

 

2011

Fan

USA

US Caucasian

Taqman

389

308

0.73 (0.58–0.90)

0.0045

PB

Yes

 

2011

Burdon

Australia

Caucasian

Illumina

892

4582

1.44 (1.28- 1.61)

7.46 × 10−10

PB

Yes

 

2014

Vishal

India

Asian (East Indians)

Illumina

700

708

0.98 (0.77–1.26)

0.9

HB

No

 

2019

Present study

India

Asian

RT-PCR

313

449

1.04 (0.82–1.30)

0.726

HB

No

rs2157719 (A > G)

 

2016

Abu-Amero

Saudi Arabia

Caucasian

Taqman

85

95

1.2 (0.73–2.07)

0.429

HB

No

 

2015

Chen

China

Asian

Sequenom

1157

934

0.64 (0.52–0.79)

3.528 × 10−5

HB

Yes

 

2017

Shiga

Japan

Asian

Japonica Array

565

1104

1.61 (1.29–2.00)

1.42E10−5

PB

Yes

 

2014

Vishal

India

Asian (East Indian)

Illumina

700

708

0.96 (0.75–1.23)

0.76

HB

No

 

2019

Present Study

India

Asian

RT-PCR

312

442

0.77 (0.62–0.97)

0.0279

HB

Yes

rs4977756 (A > G)

 

2014

Michael

Pakistan

Asian

Taqman

268

233

0.92 (0.68–1.23)

0.55

HB

No

 

2013

Liu

USA

African American

Real time PCR

1150

999

0.91 (0.81–1.04)

0.16

PB

No

 

2013

Liu

USA

West African

Real time PCR

483

593

1.07 (0.90–1.29)

0.44

PB

No

 

2017

Yoshikawa

Japan

Asian

Taqman

736

2723

0.77

3.2 X 10−4

HB

Yes

 

2011

Burdon

Australia

Caucasian

Illumina

892

4582

1.33 (1.19–1.48)

4.19 × 10−7

PB

Yes

 

2016

Ng

Australia

Caucasian

Illumina

2241

3176

1.40 (1.26–1.52)

1.97 × 10−16

HB

Yes

 

2015

Chen

China

Asian (Han Chinese)

Sequenom

1157

934

0.89 (0.76–1.04)

0.128

HB

No

 

2012

Cao

West Indies

Afro-Carribean

PCR

272

165

0.89 (0.67–1.20)

0.4507

PB

No

 

2014

Vishal

India

Asian

Illumina

700

708

0.99 (0.78–1.27)

0.95

HB

No

 

2015

Burdon

Australia

Caucasian

PCR

67

1919

1.52 (1.05–2.20)

0.027

PB

Yes

 

2015

Williams

South African

African

Illumina

215

214

1.14 (0.59–2.18)

0.6974

HB

No

 

2019

Present study

India

Asian

RT-PCR

313

444

0.80 (0.58–1.09)

0.168

HB

No

rs3217992 (C > T)

 

2011

Burdon

Australia

Caucasian

Illumina

892

4582

1.22 (1.09- 1.37)

5.04 × 10−4

PB

Yes

 

2012

Takamoto

Japan

Asian

Digitag2 Assay

183

514

1.53 (1.20–1.96)

6.35 × 10–4

HB

Yes

 

2014

Vishal

India

Asian (East Indians)

Illumina

700

708

1.15 (0.93–1.42)

0.21

HB

No

 

2019

Present study

India

Asian

RT-PCR

313

444

0.80 (0.65–0.99

0.045

HB

Yes

  1. PB population based, HB hospital based, CON control, OR odds ratio